Avasopasem manganese is a potent superoxide dismutase mimetic | MedChemExpress (MCE)-产品咨询-资讯-生物在线

Avasopasem manganese is a potent superoxide dismutase mimetic | MedChemExpress (MCE)

作者:MedChemExpress LLC 暂无发布时间 (访问量:11902)

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

Avasopasem manganese

MCE:Avasopasem manganese

Brand:MedChemExpress (MCE)

Cat. No:HY-109110

CAS:435327-40-5

Synonyms:GC-4419; M-40419

Purity0.9602

Storage:

Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month

Shipping:Room temperature in continental US; may vary elsewhere.

Description:Avasopasem manganese (GC4419; M-40419) is a potent superoxide dismutase mimetic that rapidly and specifically converts O2*- to hydrogen peroxide (H2O2), arresting the initiation of this cascade. Avasopasem manganese can be used for the research of severe oral mucositis (SOM) and cancer[1].

In Vivo:

Avasopasem manganese is an agent intended to interrupt severe oral mucositis pathogenesis, to reduce the duration, incidence, and severity of radiation-induced oral mucositis[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Hot product:PF-01247324  | PXYC1  | Crizanlizumab  | Margatoxin  | Clonidine  | TMB  | Mometasone furoate  | U-73343  | NSC697923  | Dehydroglyasperin C

Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

References:

[1]. Anderson CM, et al. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer [published correction appears in J Clin Oncol. 2020 Jan 20;38(3):288]. J Clin Oncol. 2019;37(34):3256-3265.

Brand Introduction:

• MCE (MedChemExpress) has a global exclusive compound library of more than 200 kinds, and we are committed to providing global scientific research customers with the most comprehensive range of high-quality small molecule active compounds;


• More than 50,000 highly selective inhibitors and agonists involved in various popular signaling pathways and disease areas;


• Product categories cover a variety of recombinant proteins, peptides, commonly used kits, more PROTAC, ADC and other specialty products, widely used in new drug research and development, life science and other scientific research projects;


• Provide virtual screening, ion channel screening, metabolomics analysis detection analysis, drug screening and other professional technical services;

• Professional experimental center and strict quality control and verification system;

• Provide LC/MS, NMR, HPLC, chiral analysis, elemental analysis and other quality inspection reports to ensure the high purity and high quality of products;

• The biological activity of the products has been experimentally verified by customers from various countries;


A variety of top journals such as Nature, Cell, Science and pharmaceutical patents have included the scientific research results of MCE customers;


• Professional team to track the latest pharmaceutical and life science research progress, to provide you with the world's latest active compounds;


• Established long-term cooperation with the world's major pharmaceutical companies and well-known scientific research institutions.

类药多样性化合物库
顾客使用MCE产品发表的科研文献
重组蛋白 | 高纯度、高稳定性
磁珠
 
MedChemExpress LLC 商家主页

地 址: 上海市浦东新区张衡路1999弄3号楼

联系人: 销售部

电 话: 021-58955995

传 真: 021-53700325

Email:sales@medchemexpress.cn

相关咨询
ADVERTISEMENT